Literature DB >> 6897199

The effects of pH on the affinity of pirenzepine for muscarinic receptors in the guinea-pig ileum and rat fundus strip.

R B Barlow, M Chan.   

Abstract

1 Dose-ratios obtained with pirenzepine on the guinea-pig ileum at 30 degrees C are indistinguishable from those obtained at 37 degrees C. 2. In 0.1 M NaCl at 37 degrees C the pKa of pirenzepine for the loss of its last ionizable proton is 8.2. The ionization of pirenzepine is therefore markedly affected by changes in pH in the physiological range. 3 In experiments with pirenzepine on guinea-pig ileum and rat fundus made over a range of pH, the dose-ratio increases with the proportion of the protonated form present. As expected, the slope of the graph of dose-ratio against proportion protonated depends on the concentration of antagonist. The changes in pH produce only small effects on dose-ratios obtained with pirenzepine monomethiodide. These effects of pH can account for some of the differences between estimates of the affinity of pirenzepine. 4 The logarithm of the affinity constant of the protonated form of pirenzepine for the receptors in guinea-pig ileum is estimated to be 6.93, compared with 6.94 for the receptors in rat fundus. However, for the non-protonated form the values appear to be below 5 for the ileum compared with about 6.4 for the rat fundus.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6897199      PMCID: PMC2044615          DOI: 10.1111/j.1476-5381.1982.tb09331.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  8 in total

1.  Use of the logistic function for the calculation of dose-ratios and potency ratios.

Authors:  R B Barlow
Journal:  Br J Pharmacol       Date:  1975-01       Impact factor: 8.739

2.  Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. II. Competitive antagonists.

Authors:  D R Waud; R B Parker
Journal:  J Pharmacol Exp Ther       Date:  1971-04       Impact factor: 4.030

3.  Antagonist discrimination between ganglionic and ileal muscarinic receptors.

Authors:  D A Brown; A Forward; S Marsh
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

4.  The ionization of phenolic amines, including apomorphine, dopamine and catecholamines and an assessment of zwitterion constants.

Authors:  J Armstrong; R B Barlow
Journal:  Br J Pharmacol       Date:  1976-08       Impact factor: 8.739

5.  Affinities of the protonated and non-protonated forms of hyoscine and hyoscine N-oxide for muscarinic receptors of the guinea-pig ileum and a comparison of their size in solution with that of atropine.

Authors:  R B Barlow; E A Winter
Journal:  Br J Pharmacol       Date:  1981-04       Impact factor: 8.739

6.  Pirenzepine distinguishes between different subclasses of muscarinic receptors.

Authors:  R Hammer; C P Berrie; N J Birdsall; A S Burgen; E C Hulme
Journal:  Nature       Date:  1980-01-03       Impact factor: 49.962

7.  A sensitive method for the assay of 5-hydroxytryptamine.

Authors:  J R VANE
Journal:  Br J Pharmacol Chemother       Date:  1957-09

8.  Temperature coefficients of affinity and entropies of adsorption from enantiomeric pairs of compounds acting at muscarinic receptors in the guinea-pig ileum.

Authors:  R B Barlow; K N Burston
Journal:  Br J Pharmacol       Date:  1979-08       Impact factor: 8.739

  8 in total
  10 in total

1.  Different behavior toward muscarinic receptor binding between quaternary anticholinergics and their tertiary analogues.

Authors:  K Ensing; R A de Zeeuw
Journal:  Pharm Res       Date:  1986-12       Impact factor: 4.200

2.  Pharmacological analysis of muscarinic receptors coupled to oxyntic cell secretion in the mouse stomach.

Authors:  J W Black; N P Shankley
Journal:  Br J Pharmacol       Date:  1985-11       Impact factor: 8.739

3.  Prediction of Membrane Permeation of Drug Molecules by Combining an Implicit Membrane Model with Machine Learning.

Authors:  Stephanie A Brocke; Alexandra Degen; Alexander D MacKerell; Bercem Dutagaci; Michael Feig
Journal:  J Chem Inf Model       Date:  2018-12-27       Impact factor: 4.956

4.  Autoregulation of acetylcholine release from vagus nerve terminals through activation of muscarinic receptors in the dog trachea.

Authors:  Y Ito; T Yoshitomi
Journal:  Br J Pharmacol       Date:  1988-03       Impact factor: 8.739

5.  The relative potencies of cholinomimetics and muscarinic antagonists on the rat iris in vivo: effects of pH on potency of pirenzepine and telenzepine.

Authors:  J J Hagan; B van der Heijden; C L Broekkamp
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-11       Impact factor: 3.000

6.  Influence of monovalent cations on the binding of a charged and an uncharged ('carbo'-)muscarinic antagonist to muscarinic receptors.

Authors:  X Hou; J Wehrle; W Menge; E Ciccarelli; J Wess; E Mutschler; G Lambrecht; H Timmerman; M Waelbroeck
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

7.  The contribution of charge to affinity at functional (M3) muscarinic receptors in guinea-pig ileum assessed from the effects of the carbon analogue of 4-DAMP methiodide.

Authors:  R B Barlow; S Bond; D W Holdup; J A Howard; D S McQueen; A Paterson; M A Veale
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

8.  Heterogeneous distribution of muscarinic receptors in the rabbit saphenous artery.

Authors:  K Komori; H Suzuki
Journal:  Br J Pharmacol       Date:  1987-11       Impact factor: 8.739

9.  Binding and functional properties of hexocyclium and sila-hexocyclium derivatives to muscarinic receptor subtypes.

Authors:  M Waelbroeck; J Camus; M Tastenoy; R Feifel; E Mutschler; R Tacke; C Strohmann; K Rafeiner; J F Rodrigues de Miranda; G Lambrecht
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

10.  The binding of pirenzepine to digitonin-solubilized muscarinic acetylcholine receptors from the rat myocardium.

Authors:  N J Birdsall; E C Hulme; M Keen
Journal:  Br J Pharmacol       Date:  1986-02       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.